“…reading through this trial and learning about this weird part of the adtech world, did teach me about why corporate America, and the pharmaceutical industry, is so bloated and over-priced. Fundamentally, the data IQVIA has, through its payment of the owners of switches, is our data, and yet IQVIA gets to monetize it and use it as a competitive weapon. None of us, not the pharmacy, or the doctor, or anyone else, consented to give our data to help a would-be monopolist festival of bros as they joke about bags of money. And until the FTC under Lina Khan filed suit, no one had ever told these guys ‘no’ to their strategy of destroying rivals to squeeze out cash, and so they act with impunity to do so. And why wouldn’t they? If these executives weren’t rolling up this new market, someone else would. And that will remain the case, until and unless a judge puts a stop to it, as per the Clayton Act.”